Millipore Sigma Vibrant Logo

SCC257 OVCAR-3 Human Ovarian Cancer Cell Line

OVCAR-3 cell line is a well-established model system for ovarian carcinoma.

SCC257
≥1X10⁶ cells/vial   
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Fulfillment and delivery delayed Fulfillment and delivery delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberSCC257
      DescriptionOVCAR-3 Human Ovarian Cancer Cell Line
      Alternate Names
      • OVCAR3
      Background InformationOvarian carcinoma is a prevalent worldwide disease, with over 200,000 new cases diagnosed per year (1). The first-line chemotherapy for newly-diagnosed ovarian carcinoma is cisplatin, but despite high initial efficacy, the most common types of ovarian carcinomas frequently relapse into platinum-resistant forms and many demonstrate multi-drug resistance (1). The availability of cellular models that recapitulate both resistant and susceptible forms of the disease are essential to understanding drug resistance and advancing new options for treatment.

      OVCAR-3 is a high-grade serous ovarian adenocarcinoma cell line established from a patient refractory to cisplatin, however the cell line remains sensitive to a variety of chemotherapeutic drugs (2). OVCAR-3 cells demonstrate increased glutathione content (3) and express the Wilms Tumor 1 protein (WT1), a marker of advanced serous ovarian carcinoma (4). OVCAR-3 cells are characterized by migration/invasion ability and are tumorigenic in nude mice (5). The OVCAR-3 cell line is well-established and one of the most highly-cited model systems for ovarian carcinoma.

      Source:
      OVCAR-3 was established from ascitic fluid from a 60-year-old patient with ovarian cancer refractory to cisplatin treatment (2).

      References:
      1. Nat Rev Disease Primers 2016; 2:16061.
      2. Cancer Res 1997; 57:850—856.
      3. Proc Natl Acad Sci USA 1992; 89:3070-3074.
      4. BMC Cancer 2006; 6:90.
      5. Gynecol Oncol 2015;138(2):372-377.
      References
      Product Information
      Applications
      ApplicationOVCAR-3 cell line is a well-established model system for ovarian carcinoma.
      Key Applications
      • Cell Culture
      Application NotesThis product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.
      Biological Information
      Cell Line Type
      • Cancer Cells
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality Assurance• Each vial contains ≥ 1X10⁶ viable cells.
      • Cells are tested negative for infectious diseases by a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.
      • Cells are verified to be of human origin and negative for inter-species contamination from rat, mouse, chinese hamster, Golden Syrian hamster, and non-human primate (NHP) as assessed by a Contamination CLEAR panel by Charles River Animal Diagnostic Services.
      • Cells are negative for mycoplasma contamination.
      • Each lot of cells is genotyped by STR analysis to verify the unique identity of the cell line.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStore in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
      Packaging Information
      Material Size≥1X10⁶ cells/vial
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      SCC257 04061842403479